Port Hueneme’s Stellar Biotechnologies posts mixed earnings results

Stellar Biotechnologies saw revenues increase 130 percent during the first quarter of 2016 but the company still lost more money in 2016 than it did during the same quarter of 2015. The Port Hueneme-based company reported first quarter 2016 results after markets closed Feb. 8. Stellar makes a protein for immunotherapy treatments using a unique Read More →
Sientra breast implants to be back on market March 1

Sientra breast implants will be returning to U.S. doctors’ offices on March 1, almost five months after the Goleta company pulled the products off the market. Sientra released the news Feb. 8 in a filing with the Securities and Exchange Commission just before markets opened at 6:26 a.m. The company pulled its products from the Read More →

Thousand Oaks’ Amgen just keeps chugging along

This article is only available to Business Times subscribers Subscribers: LOG IN or REGISTER for complete digital access. Not a Subscriber? SUBSCRIBE for full access to our weekly newspaper, online edition and Book of Lists. Check the STATUS of your Subscription Account.
Amgen drug Kyprolis gets another FDA approval

Amgen scored another victory for its breakthrough multiple myeloma drug on Jan. 21. The Thousand Oaks-based biotech giant hit it big when the Food and Drug Administration approved revolutionary multiple myeloma drug Kyprolis for treatments with Kyprolis in combination with another drug. The FDA also approved Kyprolis to treat patients on its own for those Read More →